Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Research Paper | Synapse

January 1, 2020Open Access

Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment

DGDan GuoGuangxi University PXPeipei XuNanjing Drum Tower Hospital DCDangui ChenAnqing City Hospital

Key Points

Key points are not available for this paper at this time.

Abstract

The system of DNR-CdTe-CD123 enhances the therapeutic effects and reduce the side effects of DNR, thus providing a novel platform for MDS treatment.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Guo et al. (Wed,) studied this question.

synapsesocial.com/papers/69df2b3ede200760a86147e9 https://doi.org/https://doi.org/10.2147/ijn.s233395

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Long‐term follow‐up of <i>de novo</i> myelodysplastic syndromes treated with intensive chemotherapy: incidence of long‐term survivors and outcome of partial responders1997 · 80 citations
2Untitled2015 · 15 citations
3Magnetic nanoparticles for theragnostics2009 · 1,023 citations
4Antigen/Antibody Immunocomplex from CdTe Nanoparticle Bioconjugates2002 · 527 citations
5Advances in supportive care of myelodysplastic syndromes.1999 · 25 citations